» Authors » Steven Bollipo

Steven Bollipo

Explore the profile of Steven Bollipo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 430
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vlismas L, Potter M, Loewenthal M, Wilson K, Allport K, Gillies D, et al.
Intern Med J . 2024 Sep; 54(11):1867-1875. PMID: 39301935
Background And Aim: Barrett's oesophagus predisposes individuals to oesophageal adenocarcinoma (OAC), with the risk of progression to malignancy increasing with the degree of dysplasia, categorized as either low-grade dysplasia (LGD)...
2.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel) . 2024 Sep; 16(17). PMID: 39272868
Percutaneous ablation is recommended in Barcelona Clinic Liver Cancer (BCLC) stage 0/A patients with HCC ≤3 cm as a curative treatment modality alongside surgical resection and liver transplantation. However, trans-arterial...
3.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893086
The management of early-stage hepatocellular carcinoma (HCC) is complex, with multiple treatment strategies available. There is a paucity of literature regarding variations in the patterns of care and outcomes between...
4.
Abdelmalak J, Strasser S, Ngu N, Dennis C, Sinclair M, Majumdar A, et al.
Cancers (Basel) . 2023 Dec; 15(24). PMID: 38136287
The optimal treatment approach in very-early and early-stage hepatocellular carcinoma (HCC) is not precisely defined, and there is ambiguity in the literature around the comparative efficacy of surgical resection versus...
5.
Clark P, Valery P, Strasser S, Weltman M, Thompson A, Levy M, et al.
J Gastroenterol Hepatol . 2023 Dec; 39(3):568-575. PMID: 38114452
Background: Direct-acting antiviral (DAA) therapies for hepatitis C virus infection (HCV) lead to excellent rates of sustained virological response (SVR). However, loss to follow-up (LTFU) for SVR testing remains a...
6.
Grover S, Ong A, Bollipo S, Dilly C, Siau K, Walsh C
Gastroenterology . 2023 Oct; 165(6):1323-1327. PMID: 37832593
No abstract available.
7.
Burns G, Potter M, Mathe A, Bruce J, Minahan K, Barnes J, et al.
Clin Transl Gastroenterol . 2023 Sep; 14(12):e00638. PMID: 37753952
Introduction: An association between functional dyspepsia (FD) and wheat-containing foods has been reported in observational studies; however, an adaptive response has not been demonstrated. We examined whether antigens present in...
8.
Janko N, Majeed A, Clements W, Fink M, Lubel J, Goodwin M, et al.
Hepatol Commun . 2023 Apr; 7(5). PMID: 37102761
Background And Aims: Recent guidelines recognize the limitations of standard coagulation tests in predicting bleeding and guiding pre-procedural blood component prophylaxis in cirrhosis. It is unclear whether these recommendations are...
9.
Burns G, Bruce J, Minahan K, Mathe A, Fairlie T, Cameron R, et al.
Front Immunol . 2023 Jan; 13:1051632. PMID: 36685573
Background: Functional dyspepsia is characterised by chronic symptoms of post-prandial distress or epigastric pain not associated with defined structural pathology. Increased peripheral gut-homing T cells have been previously identified in...
10.
Phonlakrai M, Ramadan S, Simpson J, Gholizadeh N, Arm J, Skehan K, et al.
J Med Radiat Sci . 2022 Sep; 70 Suppl 2:48-58. PMID: 36088635
Introduction: In this study, we aimed to investigate the feasibility of gadoxetate low-temporal resolution (LTR) DCE-MRI for voxel-based hepatic extraction fraction (HEF) quantification for liver sparing radiotherapy using a deconvolution...